Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
04/2011
04/20/2011CN1930190B Hyaluronic acid derivative and drug containing the same
04/20/2011CN1928111B Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes
04/20/2011CN1909929B Anti-inflammatory analgesic for external use
04/20/2011CN1901896B Use of selected amino acid-zinc complexes as anti-malarials
04/20/2011CN1628179B Detection of hepatocellular carcinoma
04/20/2011CN102026987A Therapeutic agent for pain
04/20/2011CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis
04/20/2011CN102026661A Nutrient composition capable of adjusting energy amount, water amount and salt equivalent
04/20/2011CN102026645A Oncolytic rhabdovirus
04/20/2011CN102026641A Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form
04/20/2011CN102026640A sGC stimulators, sGC activators and combinations thereof for the treatment of hearing impairment
04/20/2011CN102018959A Method and reagent for preventing and treating heart disease
04/20/2011CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
04/20/2011CN102018693A Topical co-enzyme q10 formulations and methods of use
04/20/2011CN102018672A Freeze-dried liposome composition of water-soluble medicament and preparation method thereof
04/20/2011CN102018670A Anticancer preparation and preparation method thereof
04/20/2011CN102018667A Imidazoles antifungal skin wiping agent and preparation method thereof
04/20/2011CN102018658A Controlled release preparation and preparation method thereof
04/20/2011CN102018657A Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same
04/20/2011CN101530618B Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma
04/20/2011CN101502484B Glucocorticosteroid and chemotherapy medicament carried by anticancer sustained-release agent
04/20/2011CN101254305B Composite nasal cavity preparations for curing allergic rhinitis
04/20/2011CN101224306B Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof
04/19/2011US7928206 Pharmaceutical composition comprising a thymidine kinase polynucleotide
04/19/2011US7928146 Topical applying adrenergic blocking agent, nitric oxide synthase inhibitor, prostaglandin, dopamine, morphine and 5-hydroxytryptamine; topical applying
04/19/2011US7928128 Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
04/19/2011US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
04/19/2011US7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
04/19/2011US7928081 Combined use of PRAME inhibitors and HDAC inhibitors
04/19/2011US7928074 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders
04/19/2011US7928073 Purified polypeptides having IL-13 receptor activity
04/19/2011US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications
04/19/2011US7927821 Methods of screening for compounds which bind G protein-coupled receptors
04/19/2011US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
04/19/2011US7927627 Nanoparticulate fibrate formulations
04/19/2011US7927612 Combinations and methods for treating neoplasms
04/19/2011US7927606 Modified free-living microbes, vaccine compositions and methods of use thereof
04/19/2011US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
04/19/2011US7927365 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
04/19/2011US7927364 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
04/19/2011CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/19/2011CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/19/2011CA2458452C Gnrh agonist combination drugs
04/19/2011CA2440557C Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof
04/19/2011CA2400969C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine
04/19/2011CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties
04/19/2011CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
04/19/2011CA2220116C Dna encoding glutamate gated chloride channels
04/14/2011WO2011044122A1 Compositions and methods of treatment that include plant extracts
04/14/2011WO2011043435A1 Therapeutic agent for influenza virus infectious diseases
04/14/2011WO2011042565A2 Antiprotozoal activity
04/14/2011WO2010120649A3 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation
04/14/2011WO2010031832A9 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
04/14/2011WO2010012733A9 Use of a cdk inhibitor for the treatment of glioma
04/14/2011US20110086926 Disabling thymus gland as a new method for treatment of multiple sclerosis
04/14/2011US20110086917 Use of l-carnitine for the treatment of cardiovascular diesases
04/14/2011US20110086907 Acne treatment
04/14/2011US20110086826 Liposomal camptothecins and uses thereof
04/14/2011US20110086821 Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders
04/14/2011US20110086119 Preparation for the relief of disease
04/14/2011US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
04/14/2011US20110083991 Hyaluronic acid derivative and drug containing the same
04/13/2011EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis
04/13/2011EP2308963A2 System for processing lipoaspirate cells
04/13/2011EP2308893A1 Potassium channel mutants of S. cerevisiae and their use for the screening of eucaryotic potassium channels
04/13/2011EP2308855A1 2,4-Diaminopyrimidine derivatives
04/13/2011EP2308833A2 Cyclic protein tyrosine kinase inhibitors
04/13/2011EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors
04/13/2011EP2308510A1 Agent for regeneration and/or protection of nerves
04/13/2011EP2308509A1 Inhibitor of analgesic tolerance
04/13/2011EP2308479A2 Compounds and compositions for delivering active agents
04/13/2011EP2308476A1 Colonic purgative composition with soluble binding agent
04/13/2011EP2308473A1 Pharmaceutical composition containing surface-coated microparticles
04/13/2011EP2307053A2 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug
04/13/2011EP2307052A2 Anti-beta-2-microglobulin agents and the use thereof
04/13/2011EP2307040A1 Method and means for treating viral disease, in particular hiv/aids
04/13/2011EP2307033A2 Use of oncolytic herpes viruses for killing cancer stem cells
04/13/2011EP2307027A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
04/13/2011EP2307016A2 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate
04/13/2011EP2307010A1 Thiazole compounds, and compositions and methods using same
04/13/2011EP2307002A1 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
04/13/2011EP2307000A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
04/13/2011EP2306999A2 Compositions for treating rosacea
04/13/2011EP2306998A1 Pharmaceutical formulation
04/13/2011EP2306836A1 Bmi-1 protein expression modulators
04/13/2011EP2205279B1 Pharmaceutical combination of aliskiren and valsartan
04/13/2011EP1539763B1 Azaindole kinase inhibitors
04/13/2011EP1140085B1 Azabicycloalkanes as ccr5 modulators
04/13/2011CN1958568B A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application
04/13/2011CN1956726B Composition and method for releasing mammal inflammation and oxidation stress
04/13/2011CN1874774B Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
04/13/2011CN1839806B Methods for in vivo delivery of biologics and compositions useful therefor
04/13/2011CN102014960A Pharmaceutical composition based on hepatoprotector and prebiotic, the production and use thereof
04/13/2011CN102014913A Combination therapy with C-MET and EGFR antagonists
04/13/2011CN102014895A Combination anti-cancer agents
04/13/2011CN102014889A Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
04/13/2011CN102008730A Transdermal medicine composition and transdermal medicine kit
04/13/2011CN102008726A Dexiburofen amino acid salt-containing medicament for colds
04/13/2011CN102008725A Application of human UTP14a expression inhibitor to preparation of cell proliferation inhibitor
04/13/2011CN102008724A Method and reagent for inhibiting hepatocellular carcinoma